Abstract
Restless legs syndrome is a common sensorimotor movement disorder affecting an estimated 15–20% of the general adult population in the United Sates. Several drugs and drug classes have been shown to either cause and/or exacerbate symptoms of restless legs syndrome. With the epidemic of obesity and the heightened awareness of the harmful effects of added sugars, the consumption of low and no-calorie sweeteners has substantially increased. We report a case where the patient developed restless legs syndrome symptoms with the use of a stevia extract–based no calorie sweetener. To our knowledge, this is the first case report of restless legs syndrome possibly associated with low or no-calorie sweetener use.
Original language | English (US) |
---|---|
Pages (from-to) | 1819-1821 |
Number of pages | 3 |
Journal | Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine |
Volume | 16 |
Issue number | 10 |
Early online date | Jul 21 2020 |
DOIs | |
State | Published - Oct 15 2020 |
Bibliographical note
Publisher Copyright:Copyright 2020 American Academy of Sleep Medicine. All rights reserved.
Keywords
- dopamine
- obesity
- restless legs syndrome
- RLS
- stevia
- Restless legs syndrome
- Dopamine
- Stevia; obesity
PubMed: MeSH publication types
- Case Reports